Skip to main content
    K

    KORU Medical Systems, Inc. (KRMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.49
    -0.20 (-5.42%)

    Market Cap: $160.05M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    KORU Medical Systems, Inc. (KRMD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    KORU Medical Systems (KRMD) has a market cap of $160.05M. Its trailing P/E is 154.4x.

    Total Valuation

    Market Cap$160.05M
    Latest price (Nov 17, 2026)$3.49

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 5.61% in the quarter ended Sep 30, 2026 and grew 0.96% a year over 2 years.

    Shares Outstanding46.73M
    Shares Change (YoY)+1.07%
    Shares Change (QoQ)-5.61%
    Share Count Growth (2Y CAGR)+0.96%

    Valuation Ratios

    The price to sales ratio is 3.5x. Its year-end P/E ranged from 27.5x to 200.7x from 2016 to 2020.

    P/E Ratio154.4x
    P/S Ratio3.5x
    Forward P/S3.3x
    P/OCF Ratio361.5x

    Valuation history and multiples

    Price Statistics

    The stock is down 19.21% over 52 weeks and trades 10.09% above its 50-day average.

    Beta (1Y)1.19
    52-Week Change-19.21%
    1-Month Change+15.56%
    3-Month Change+5.12%
    6-Month Change-11.87%
    5-Year Change+20.08%
    10-Year Change+557.14%
    Total Return (1Y)-19.21%
    Total Return (3Y CAGR)+15.24%
    Total Return (5Y CAGR)+0.64%
    Return vs SPY (1Y)-33.48%
    Max Drawdown (1Y)-55.06%
    Max Drawdown (3Y)-57.96%
    Sharpe Ratio (1Y)-0.48
    Correlation with SPY (1Y)0.32
    50-Day Average$3.17
    200-Day Average$3.89
    52-Week Range$2.86 to $6.61
    RSI (14 Days)56.2
    Average Volume (20 Days)200.49K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.97x current liabilities.

    Current Ratio2.97x
    Quick Ratio2.27x

    Returns and Efficiency

    Return on equity is 0.00% over the last 12 months, against a 5-year average of -31.84%.

    Return on Equity (ROE)0.00%
    Return on Assets (ROA)0.00%
    Return on Capital Employed (ROCE)0.00%
    ROE (5Y Average)-31.84%
    ROA (5Y Average)-22.29%
    ROIC (5Y Average)-26.60%
    Asset Turnover0.00x
    Inventory Turnover0.00x
    Receivables Turnover7.08x
    Cash Conversion Cycle50285572 days

    Scores

    KRMD has an Altman Z-Score of -1.02, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-1.02
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $46.27M over the last 12 months is up 18.43% from the 12 months before.

    Revenue$46.27M
    Revenue Growth (YoY)+18.43%
    Gross Profit$29.24M
    Operating Income-$597.92K
    Pretax Income-$794.90K
    Net Income-$823.38K
    EBITDA$1.86K
    EBIT-$794.90K
    Reported EPS (TTM)$0.02

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 67.41% of the $28.78T in total assets.

    Cash and Equivalents$7.36T
    Working Capital$13.35T
    Shareholder Equity$19.40T
    Book Value Per Share$415,029.47
    Tangible Book Value$17.71T
    Tangible Book Per Share$378,999.94
    Total Assets$28.78T
    Total Liabilities$9.39T

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.34M of capital spending, operating cash flow left -$900.55K of free cash flow.

    Operating Cash Flow$442.70K
    Capital Expenditures$1.34M
    Free Cash Flow-$900.55K
    FCF Per Share-$0.02
    Depreciation and Amortization$793.68K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1.29%, against a 5-year average of -26.19%.

    Gross Margin63.20%
    Operating Margin-1.29%
    Pretax Margin-1.72%
    Net Margin-1.78%
    EBITDA Margin0.00%
    EBIT Margin-1.72%
    FCF Margin-1.95%
    Gross Margin (5Y Average)59.59%
    Operating Margin (5Y Average)-26.19%
    Net Margin (5Y Average)-24.62%

    Growth

    Revenue grew 13.81% a year over 3 years.

    Revenue Growth (3Y CAGR)+13.81%
    Revenue Growth (5Y CAGR)+11.21%
    Book Value Per Share Growth (2Y CAGR)-8.99%
    Tangible Book Per Share Growth (2Y CAGR)-9.14%

    Revenue and profit by year

    Dividends and Yields

    KRMD does not pay a dividend. Its free cash flow yield is -0.55%.

    Earnings Yield0.65%
    FCF Yield-0.55%
    Shareholder Yield0.00%

    Peer Position

    Against 5 similar companies, KRMD has the highest P/E.

    P/E Ratio154.4x vs 20.7x median
    P/S Ratio3.5x vs 2.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+18.43% vs +8.63% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 16.68% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+16.68%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About KRMD

    What is KRMD's market cap?

    KORU Medical Systems has a market cap of $160.05M.

    What is KRMD's P/E ratio?

    KORU Medical Systems has a trailing P/E ratio of 154.4x.

    How many shares of KRMD are outstanding?

    KORU Medical Systems has 46.73M shares outstanding. The count is up 1.07% from a year earlier.

    Does KRMD pay a dividend?

    No. KORU Medical Systems does not pay a dividend.